Clinical Trial Update: High-Density Lipoprotein (HDL) Modulation and Endothelial Function [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating high-density lipoprotein modulation and its effect on endothelial function in atherosclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Snippet

Sponsor: University of Calgary | Conditions: Atherosclerosis | Phase 3 | Status: COMPLETED